BACKGROUND: Recent policy efforts have focused on improving the value of acute myocardial infarction (AMI) care. Medicare payment programs, for example, increasingly evaluate hospital performance based on spending, as determined by payments made to institutions and providers, and outcome measures for a longitudinal episode of AMI care. Little is known about the relationship between total 30-day paymentsboth in the inpatient and immediate postdischarge timeframe-and outcomes after an admission for AMI.
I
n recent years, there has been growing policy focus on increasing the value of acute myocardial infarction (AMI) care, by improving both AMI care quality and the cost with which care is delivered. This has been spurred, in part, by rising Medicare expenditures for AMI care and by evidence of significant geographic variation in cardiac resource utilization and Medicare spending. [1] [2] [3] [4] Increasingly, Centers for Medicare and Medicaid Services (CMS) payment programs aim to incentivize reductions in spending as determined by Medicare payments made to providers and institutions, as well as improved clinical outcomes for an episode of AMI care.
The mandatory Hospital Value-Based Purchasing (HVBP) Program, for example, puts a growing proportion of hospitals' revenue at risk based on performance on payment and outcome measures for a 30-day episode of AMI care, among other conditions. [5] [6] [7] In addition, the recent expansion of the voluntary bundled payment program will result in a greater number of hospitals being held financially accountable for both payments and outcomes for a longitudinal episode of AMI care. Given this shift toward value-based reimbursement models, understanding the relationship between episode payments and outcomes is increasingly important. Prior studies have demonstrated significant variation in Medicare payments for a 30-day episode of AMI care, but it is not clear what these variations mean for value. 8, 9 Higher episode payments may be because of procedure, resource, and postacute care use that improve outcomes, which would reflect higher value care. However, it is also possible that high payments are driven by the over or inappropriate use of resources and result in worse care, which would potentially indicate lower value. No prior studies have evaluated the association between total episode payments across 30 days, reflecting both inpatient and postdischarge care, and outcomes after a hospitalization for AMI.
In this study, we sought to answer several questions. First, how do hospitals that care for patients with AMI that incur higher 30-day payments differ from hospitals with lower 30-day payments? Second, are higher 30-day payments (at the hospital level) across multiple care settings after an admission for AMI associated with lower patient mortality rates? And third, do variations in hospital characteristics, coronary revascularization rates, and postacute care use explain this association?
METHODS

Patient Cohort
Our patient cohort included fee-for-service Medicare beneficiaries over the age of 65 years who were hospitalized at an acute-care hospital for AMI based on principal discharge diagnosis codes from the International Classification of Diseases, Ninth Revision (410.xx [except 410.x2]), from July 1, 2011, through June 30, 2014. We applied inclusion and exclusion criteria previously used by CMS for AMI mortality rate measures. Patient characteristics included age, sex, and comorbidities that were defined based on a validated administrative claims model used to profile hospital 30-day mortality measures for AMI. 10, 11 Only one randomly selected episode of care was included for patients with >1 AMI admission across a 3-year period. 9, 10 The data for this study are available from the CMS and the CMS Hospital Compare website. 12 Analytic methods can be made available to other researchers for purposes of reproducing the results by email to the corresponding author. This study was evaluated by the Institutional Review Board at Beth Israel Deaconess Medical Center and deemed not to qualify as human subjects research requiring further approval.
Thirty-Day AMI Episode Payments
The primary exposure variable was hospital-level risk-standardized payments (which will be simply referred to as episode payments) for a 30-day episode of AMI care, a measure made publicly available by CMS on the Hospital Compare website. 9, 12 Thirty-day episode payments are calculated by summing total payments associated with a 30-day episode of AMI care for each beneficiary, beginning with an index hospital admission and across multiple care settings, services, and supplies (ie, inpatient, outpatient, skilled nursing facility [SNF] , home health, physician/clinical laboratory/ambulance services, and medical equipment). Notably, episode payments account for policy and geographic adjustments (ie, for graduate medical education, disproportionate share hospital, wage index), differences in patient characteristics, and hospital case mix. Thus, episode payments reflect true variations in hospital practice patterns, resource, and service use for patients with AMI. 9 All payments made for care after discharge are attributed to the hospital of index admission because discharge
WHAT IS KNOWN
• Higher hospital end-of-life spending intensity is associated with lower mortality after hospitalization for acute myocardial infarction.
WHAT THE STUDY ADDS
• In this contemporary analysis of 642 105 Medicare beneficiaries hospitalized for acute myocardial infarction from 2011 to 2014, the observed 30-day mortality rate was 12.9%. • Higher 30-day payments at the hospital level for acute myocardial infarction care, including both inpatient and postdischarge payments made across multiple settings after initial admission, were associated with lower 30-day patient mortality.
• Variation in hospital characteristics, rates of coronary revascularization, and post-acute care use did not explain the association between higher payments and lower mortality.
planning during a hospitalization influences payments across subsequent care settings. When a patient is transferred from one acute-care hospital to another, total 30-day payments are attributed to the first hospital where the patient was admitted. Hospitals in the Inpatient Prospective Payment System with too few AMI cases (<25) to reliably estimate episode payments were not included in the analysis. 9 We evaluated a 30-day episode of AMI care because CMS metrics through HVBP do so, making this the most policy relevant approach. We used performance data representing July 1, 2011, through June 30, 2014, which were used in the HVBP program in fiscal year 2016. 9 Episode payments were assessed on a hospital rather than patient level to examine the impact of a patient population being exposed to varying styles of care and to diminish the likelihood of patient-level confounding.
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Hospital Characteristics
Hospital characteristics were obtained from the American Hospital Association 2013 survey and included hospital size, ownership (for-profit, private not-for profit, and public), teaching status (large teaching versus others), location (urban versus rural), census region, nurse-to-patient ratio, proportion of patients with Medicare or Medicaid insurance, and cardiac service capability (percutaneous coronary intervention [PCI] and coronary artery bypass graft surgery [CABG] ). In addition, we also determined hospital fee-for-service AMI volume and the proportion of patients with AMI discharged to a SNF or with homecare services using Medicare inpatient data.
Outcomes
The primary outcome was patient-level 30-day mortality, defined as all-cause deaths within 30 days of the date of admission.
Statistical Analysis
We first classified hospitals by whether they had low (<25th percentile), average (25th-75th percentile), or high (>75th percentile) 30-day episode payments for descriptive purposes. We then compared patient and hospital characteristics across the 3 categories, using the Mantel-Haenszel χ 2 test for categorical variables and the Kruskal-Wallis test for continuous variables. We also mapped episode payments for AMI care at the county-level to examine geographic variation.
To examine the association between 30-day hospital-level episode payments and 30-day patient-level mortality in our cohort, we fit a mixed model with a logit link function and random hospital intercepts to model mortality as a function of 30-day AMI episode payments (per $1000). We constructed regression models in the following sequence: (1) unadjusted and (2) risk-adjusted for patient characteristics and comorbidities used by CMS to profile hospital 30-day mortality measures for AMI. 10 This allowed us to make inferences at the patient level about the association of being exposed to different levels of 30-day episode payments and outcomes. We then also adjusted for key hospital characteristics (ownership, teaching status, urban versus rural, region, PCI/CABG capability, AMI volume). We also explored whether specific factors related to higher hospital payments, such as intensity of procedure use (as measured by mean proportion of patients with AMI undergoing PCI or CABG within 30 days) and postacute service use (mean proportion of patients with AMI discharged to SNF or with homecare services), explained the relationship between episode payments and outcomes.
In addition, we performed several additional analyses. First, we assessed the relationship between unadjusted hospital-level inpatient payments (made to hospitals) and 30-day patient-level mortality. Second, to understand whether patients who died required more or less expensive care, 13 we assessed the relationship between patient-level inpatient payments and 30-day patient-level mortality. Third, we performed quantile regression to assess the shape of the relationship between hospital-level 30-day payments and 30-day patient outcome to understand whether the interaction between payments and patient risk of mortality varied across differing quantiles of mortality.
14 Fourth, we performed a nonparametric bootstrapping analysis of all hospitals with a replacement that randomly selected hospitals from the CMS data set with a sample size equal to total hospitals in the data set. We then refit the mixed models described above. We completed 1000 iterations to obtain the distribution of odds ratios for the association between payments and outcomes. Finally, we examined the association between 30-day episode payments and 6-month mortality after the index hospitalization.
Statistical tests were 2 sided at a significance level of 0.05. Analyses were performed using SAS version 9.4 64-bit (SAS Institute Inc, Cary, NC).
RESULTS
Study Population
Our cohort included 642 105 patients with AMI across 2319 hospitals. Patients at high and low episode payment hospitals were generally similar in age, sex, and race (Table 1) . A slightly higher proportion of patients cared for at high episode payment hospitals, compared with average and low-payment institutions, had known coronary artery disease and heart failure, although a lower proportion had a prior myocardial infarction. Otherwise, comorbid conditions were well matched.
Thirty-Day Episode Payments
Thirty-day episode payments for AMI care varied 2-fold across hospitals, with a mean value of $22 128 and a SD of $1750 ( Figure I in the Data Supplement). 8 Median episode payments per beneficiary were $20 207 in the lowest quartile of hospitals and $24 174 in the highest quartile (Table 2) . Geographic variation in county-level episode payments for AMI care are shown in Figure 1 .
Hospital Characteristics
High episode payment hospitals were larger, more likely to be teaching institutions, less likely to be publiclyowned or rural (Table 2) , and had higher Medicare fee-for-service AMI volume. Hospitals in the high episode payment group were more likely to provide cardiac services, including PCI and cardiac surgery. The median nurse staffing ratio was lower in high episode payment institutions.
Index Hospitalization Resource Use and Discharge Patterns
Procedure and resource use during and immediately after hospitalization varied across episode payment groups (Table 3) . Patients with AMI admitted to high episode payment hospitals were more likely to receive interventions, such as PCI or CABG surgery, during their initial hospitalization. Overall, 93% of PCIs and 77.5% of CABG surgeries within 30 days of admission occurred during the initial inpatient stay. Patients cared for in high episode payment hospitals had longer mean lengths of stay and were more likely to be discharged with homecare services or to a SNF.
Thirty-Day Payments and Patient Mortality
The overall observed 30-day mortality rate in our cohort was 12.9%. Observed 30-day mortality rates by low, average, and high payment groups were 13.5%, 12.6%, and 12.8%, respectively (Table 3) . Higher 30-day hospital-level payments were associated with lower patient-level 30-day mortality (unadjusted odds ratio, 0.977 for every $1000 increase; 95% confidence interval, 0.969-0.984; P<0.001; Figure 2 ). This relationship was modestly attenuated after adjustment for patient characteristics and comorbidities (odds ratio, 0.986 for every $1000 increase; 95% confidence interval, 0.979-0.992; P<0.001; Figure 3 ; Table I in the Data Supplement). When hospital characteristics were also accounted for higher payments remained associated with lower 30-day mortality (odds ratio, 0.988 for every $1000 increase; 95% confidence interval, 0.981-0.995; P<0.001). Additional adjustment for the proportion of patients with AMI undergoing revascularization within 30 days at the hospital level and mean proportion of patients with AMI discharged to a SNF or with homecare services did not significantly attenuate the relationship between payment and outcomes.
Additional Analyses
We also performed several additional analyses. First, we examined hospital-level inpatient payments and patient mortality and found that this relationship paralleled our primary findings (Table II in the Data Supplement) . Second, to assess whether the primary results may have been influenced by the fact that beneficiaries who died required less care and payments, patient-level inpatient payments and 30-day patient-level mortality were also examined. At the patient level, adjusted odds of 30-day mortality were higher for every $1000 increase in inpatient payments (Table III in the Data Supplement), diminishing the likelihood that our primary findings were because of patients who died requiring less care and payments, and consistent with prior investigations that have observed that care delivered to Medicare decedents is significantly more expensive than survivors during a hospitalization. 13 Third, we examined whether the observed association between payments and mortality was consistent across all quantile levels of patient 30-day mortality and found a predominately linear relationship ( Figure II in the Data Supplement). Fourth, we performed an iterative nonparametric bootstrapping simulation that demonstrated that the distri- bution of the odds ratios of the association between payments and outcomes among all hospitals (for model C) remained significant ( Figure III in the Data Supplement). And finally, we found that higher 30-day episode payments after an AMI hospitalization were also associated with lower 6-month mortality (Table IV in 
DISCUSSION
In this study of Medicare beneficiaries, we found that higher hospital-level 30-day episode payments after an admission for AMI, which included payments made for both inpatient and postdischarge care across multiple settings, were associated with modestly lower patientlevel 30-day mortality even after accounting for differences in patient characteristics and comorbidities. Overall, patients admitted to hospitals with 30-day payments 1 SD ($1750) above the mean, compared with hospitals 1 SD below the mean, had an associated ≈0.7% absolute lower mortality. Additional adjustment for hospital characteristics did not significantly attenuate this association. We also explored potential mediating mechanisms and found that both variation in coronary revascularization intensity and discharge disposition did not explain the relationship between higher payments and lower mortality.
Overall, our findings do not necessarily suggest a causal relationship between higher payments and better outcomes, but rather, have implications in the context of value-based payment programs that aim to improve AMI care. For instance, for the near 3000 hospitals participating in the HVBP, 30-day mortality and payment metrics comprise one half of a total score used by CMS to evaluate performance and determine financial rewards and penalties. Because hospitals and providers are held accountable for both payments and outcomes through the HVBP, it will be important to ensure that they do not respond by reducing inpatient and postacute expenditures in a manner that adversely affects patient care. Similarly, other episode-based payment programs, such as the voluntary AMI bundled payment program, which CMS recently announced would be expanded, will need to be monitored to ensure that incentives to curtail payments do not come at the expense of outcomes. 7, 15 In our study, we found that hospitals with high 30-day payments for AMI care fundamentally differed from other hospitals. High payment hospitals were more likely to have cardiac service capabilities and had higher fee-for-service AMI volumes. Higher provider- and institution-level AMI volumes have been shown to be associated with better outcomes, thus these characteristics likely indicate greater experience in caring for patients with AMI. 16, 17 High payment hospitals were also more likely to be large, teaching institutions, where admission for AMI is associated with lower 30-day mortality compared with nonteaching hospitals. 18 Notably, hospital characteristics that are associated with higher payments, and potentially higher value care, are not accounted for in episode-based payment programs, and early evidence from the HVBP suggests that these types of hospitals may be more likely to receive penalties. In contrast, some low-payment institutions that also provide low-quality care receive financial rewards, highlighting potential unintended consequences of using both payment and outcome metrics to assess hospital performance. 19 We also explored specific procedures, resources, and services that potentially explained the observed relationship between higher payments and better AMI outcomes. For example, beneficiaries at higher payment hospitals were more likely to undergo PCI and CABG during initial hospitalization and within 30 days. Patients who undergo coronary revascularization for AMI may be more likely to survive, so we examined whether variation in hospital-level 30-day revascularization rates explained our findings and found that accounting for this had a minimal effect on the relationship between payments and outcomes. In addition, because postdischarge care explains large differences in payments among hospitals, we also evaluated the impact of more frequent use of postacute care services (SNFs and home healthcare) by higher payment hospitals. 20 Although postacute care provides greater support for vulnerable patients in the postdischarge period, higher-intensity use of these services did not explain better outcomes in our study. 21, 22 This suggests that greater postacute care service use after an AMI does not necessarily imply better quality care, which is consistent with prior studies, and may perhaps reflect the significant variation in quality of SNFs and home healthcare agencies in the United States. [23] [24] [25] Further research is needed to understand the value of specific types of postacute services for beneficiaries after a hospitalization for AMI.
Because payment reform pushes hospitals and providers to bend the cost curve, understanding factors that mediate the relationship between higher payments and lower mortality for AMI will be important. Hospitals with higher 30-day payments for AMI care may use specialist services and intensive care units more commonly. 26 In addition, these hospitals may focus more resources on transitions of care and may Geographic areas in white reflect locations that did not have hospitals that were included in our study cohort.
also be better at coordinating close outpatient cardiology follow-up and collaborative ambulatory care, which are associated with greater cardiac medication adherence and lower mortality. 21, 22 An alternate, but equally important interpretation of our findings is that the reduction in 30-day mortality associated with higher payments for AMI care was modest. Given this small effect size, the additional benefit gained from higher payments, because of greater resource and service utilization, may not necessarily reflect high value care. Future cost-effectiveness analyses could provide more formal insights on the value-added, from both a patient and health systems standpoint, through greater spending on AMI care.
Our findings parallel prior analyses of inpatient AMI spending and outcomes. A study of Medicare beneficiaries in California and a subsequent national study found that hospitals with a higher end-of-life expenditure index, as determined by Medicare reimbursements in patients' last years of life, had a lower likelihood of inpatient AMI mortality. 27, 28 A more recent study by Stukel et al 29 also found that patients with AMI admitted to hospitals in Ontario with higher end-of-life expenditures had a lower likelihood of mortality at 30 days. Our findings extend this prior work, but unlike these studies, we chose to use payments specific to an episode of AMI care instead of the end-of-life expenditure index to capture variations in practice patterns and resource utilization for the clinical condition in question rather than at the end of life. 25, 27, 29, 30 Our study differs in that it evaluated AMI-specific payments for a longitudinal 30-day episode of care across multiple settings, which has contemporary policy relevance given the movement toward episode-based payment programs that hold hospitals financially accountable for performance on both payment and outcome metrics.
This study has several limitations. First, it was observational in nature, thus we are unable to make inferences about causation. Second, our cohort only included Medicare patients >65 years of age, thus our findings may not generalize to other populations. Third, patients may have varied in ways that were not captured by the comorbidities coded in Medicare claims data; however, such unmeasured severity would most likely have biased our results toward the null. And finally, we lacked a decomposition of payment data with which to identify specific mechanisms, resources, and services by which higher payments improved outcomes-this represents an important area for future study.
In summary, in a contemporary cohort of Medicare beneficiaries hospitalized for AMI across a 3-year period, higher 30-day payments at the hospital level for an episode of AMI care were associated with lower patient mortality. Our findings highlight the challenges providers and institutions may face as they are increasingly held financially responsible for both longitudinal AMI payments and clinical outcomes through emerging payment programs, such as the HVBP and bundled payments. Further research is needed to identify resources and services in the inpatient and postacute setting that improve AMI care quality, as well as low value, wasteful spending, to ensure that hospitals and providers continue to deliver high value AMI care. 
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